MedTrace Logo

Multicentre Study About the Effect of Individual Reminiscence Therapy

NCT04047238 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 251

Last updated 2020-02-18

No results posted yet for this study

Summary

This study aims to evaluate the effect of individual reminiscence therapy (RT) on the global cognitive function of people with neurocognitive disorders attending social responses and to evaluate the ability of individually applied reminiscence therapy (RT) to improve overall cognitive function, memory, executive function, mood and quality of life (QoL) of elderly people with neurocognitive impairment attending social responses. It is proposed a multicenter study with an experimental design with randomized controlled repeated measures. Participants in the intervention group will hold two RT sessions per week for three months. Control group participants will maintain their treatment as usual.

Conditions

Interventions

OTHER

Reminiscence Therapy

Intervention group will receive two Reminiscence Therapy sessions per week for 3 months. Reminiscence therapy sessions will last approximately 50 minutes and will be developed according to the following structure: * Welcome to the patient and reality orientation therapy (7 minutes) * Conducting the main activity of reminiscence (40 minutes) * Closure, thank you for the participation and farewell until the next session (3 minutes) Reminiscence therapy sessions will have an individual format and will be conducted by a therapist previously trained in the protocol and the principles of Reminiscence Therapy. The Reminiscence activities of each session will be carried out following the protocol proposed in the Book of Past and Present.

Sponsors & Collaborators

  • Rsocialform - Geriatria, Lda

    lead OTHER

Principal Investigators

  • Susana I Justo Henriques, PhD · Cediara and University of de Santiago de Compostela

  • Enrique Pérez Sáez, PhD · CRE Alzheimer and University of Salamanca

  • João L Alves Apóstolo, PhD · Nursing School of Coimbra

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-08
Primary Completion
2019-12-20
Completion
2019-12-20

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04047238 on ClinicalTrials.gov